← Back to all trials
Recruiting
NCT05719181
Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.
Conditions: Hypertension, Diabetes Mellitus, Blood Disease
Sex: All
Ages: 25 Years – 70 Years
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 32
Sponsor: University of Baghdad
Location: Iraq
Summary
Effect of Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.
Eligibility Criteria
Inclusion Criteria:Patients have good oral hygiene.Systemic healthy individuals ,Age more than18 years.Healed edentulous area for at least 6 months after tooth extraction (delayed implant protocol).Patients have at least two missing teeth in the jaw (canine to 1st molar area) indicated for the dental implant.Exclusion Criteria:Presence of systemic diseases preventing implantation.Previous implantation or augmentation of the same region.The need for additional bone augmentation procedures (such as maxillary sinus augmentation)Partial or total edentulous ridge associated with a severe knife-edge ridge .Acute infection or any pathological lesion a the implant site.Allergy to one of the materials to be used during operation.Pregnancy.Radiation therapy, bisphosphonate drugs , Osteoradionecrosis.
Source: ClinicalTrials.gov (NCT05719181). StuddyBuddy aggregates publicly available trial information.
